Showing results (811-820 of 4,505) with videos related to

Sort By:
Pageof 451
Advances in Therapy|February 25, 2016
Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant RecipientsGorden Muduma, Isaac Odeyemi, Jayne Smith-Palmer, et al.
Advances in Therapy|May 28, 2016
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective AnalysisFredrik Nyberg, Laura Horne, Robert Morlock, et al.
Advances in Therapy|May 12, 2016
Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACTAndrew Hughes, Donal Landers, Hendrik-Tobias Arkenau, et al.
Advances in Therapy|June 2, 2016
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate CancerAxel S Merseburger, Marie C Hupe
Advances in Therapy|June 4, 2016
Substantial Effects of Luseogliflozin Revealed by Analyzing Responses to Postprandial Hyperglycemia: Post Hoc Subanalyses of a Randomized Controlled StudyYoshishige Samukawa, Hirohisa Omiya, Hirotaka Watase, et al.
Advances in Therapy|November 22, 2014
Patient preferences for change in symptoms associated with opioid-induced constipationRobert S Epstein, Ali Cimen, Hannah Benenson, et al.
Advances in Therapy|November 13, 2014
Liraglutide for the treatment of type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trialsQiang Du, Yan-Jun Wang, Sheng Yang, et al.
Advances in Therapy|July 14, 2016
Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in GermanyMarika Plöthner, Dana Ribbentrop, Jan-Phillipp Hartman, et al.
Advances in Therapy|June 26, 2016
Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control StudyCharles Chapron, Jing-He Lang, Jin-Hua Leng, et al.
Advances in Therapy|June 29, 2016
Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid ArthritisGrant W Cannon, Scott L DuVall, Candace L Haroldsen, et al.
Pageof 451